DashboardWarning LettersWarning Letter Details

Reliance Life Sciences Private Limited Warning Letter Details

Warning Letter
View Letter

Reliance Life Sciences Private Limited

Recipient Title Business Head-Pharmaceuticals, Dhirubhai Ambani Life Sciences Centre R-282 Ttc Area of MIDC, Thane Belapur Road, Rabale Navi Mumbai 400701 Maharashtra India, (b)(6)
Issue DateAugust 18, 2026
FEI Number3009510975
Violations3
CountryIndia
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated

Reliance Life Sciences Private Limited FDA Warning Letter, August 18, 2026